Study Start-up enables pharmaceutical companies to leverage a BPM, Case Management and Low-code platform to automate and organize the Clinical Study Start-up process across the globe.

Study Start-up made easy

One of the key challenges faced by any global pharmaceutical company is keeping up with and adapting to the amount of change and variation in regulatory requirements around the world. The Study Start-up solution provides a way to automated the clinical study start-up process from end-to-end, providing rich user experience, flexible workflow and deep insight into the process execution into the tasks orchestrated across sites spread across the globe.

For a pharmaceutical company, when a new drug is ready to be included in a clinical trial, a fairly complicated regulatory process is followed to get the study sites ready. The Study Start-up solution orchestrates the internal collaboration of the regulatory process for circulating the new drug to various sites where it can be administered within the trial according to the Local Regulatory Health Authority.

Key Highlights

Intuitive workflow that brings information to the user as they need it
Establishes Appian as the integration point from multiple external systems, and making the data actionable though related actions
Increased performance visibility through executive dashboards
Actionable reports that highlight missing or at risk items

Study Start-up on Appian AppMarket

Princeton Blue’s Study Start-up solution has been approved by Appian and is listed on the Appian AppMarket.

Visit AppMarket

Want to Learn More?